期刊文献+

中晚期胃癌介入干预前后血清MG7-Ag、sIL-6R、VEGF的变化 被引量:4

Clinical changes in serum MG7-Ag、sIL-6R、VEGF contents before and after transcatheter arterial chemo-embolization in patients with advanced gastric cancer
下载PDF
导出
摘要 目的观察血清MG7-Ags、IL-6R、VEGF在中晚期胃癌患者介入干预前后水平变化。方法选择中晚期胃癌患者50例,其中介入干预30例,静脉化疗20例,化疗药物选用5-氟脲嘧啶、亚叶酸钙及草酸铂,分别在干预前、干预后2周、干预后4周,清晨空腹留取静脉血5 ml,室温下静置半小时,再3 000 r/min离心10 min,留取血清进行检测,MG7-Ags、IL-6R、VEGF的测定采用ELISA法。结果介入干预组中MG7-Ags、IL-6R的水平呈下降趋势,在干预后4周、干预后2周与干预前比较均有显著性差异,干预后4周与干预后2周比较亦有显著性差异,VEGF的水平在干预后2周较干预前有所增高,但干预后4周却是下降的,比较差异有显著性;静脉化疗组中MG7-Ag、VEGFs、IL-6呈下降趋势,干预后4周与干预前比较均有显著性差异,其中只有sIL-6R干预后4周与干预后2周比较有显著性差异,而MG7-Ag、VEGF干预后4周与干预后2周无显著性差异;介入干预组中MG7-Ag、VEGFs、IL-6R的水平变化较静脉化疗组明显,两组组间比较均有显著性差异(分别为F=4.356,P=0.042<0.05、F=4.078,P=0.049<0.05,F=4.389,P=0.041<0.05)。结论通过对中晚期胃癌患者动脉介入干预前后血清MG7-Ags、IL-6R、VEGF动态观察,上述三项指标在干预后均有变化,但介入干预组中MG7-Ag、VEGFs、IL-6R的水平变化较静脉化疗组明显,故MG7-Ags、IL-6R、VEGF可作为评估胃癌干预疗效及预后的一个重要参考指标。 Objective To investigate the levels of MG7-Ag、sIL-6R、VEGF in serum before and after transcatheter arterial chemo-embolization in patients with advanced gastric.Methods 30 patients who were treated with interventional treatment and 20 patients who were treated with intravenous chemotherapy.Fasting venous blood(5 ml) were collected from 50 cases with clinical in the morning,respectively on the 1st day before the treatment,the 1st,two weeks and the 1st,four weeks after treatment.The serm were static for 30 minutes,rotated for 10 minutes with 3 000 r/min.At low temperature,the serum was separated and stored in-70℃,MG7-Ag、sIL-6R、VEGF was detected with ELISA,observed the changes of MG7-Ag、sIL-6R、VEGF.Results Serum MG7-Ag、sIL-6R levels at the 1st day before the TACE,at the 1st day,two weeks,and four weeks after the treatment was significantly decreased.At the 1st day,two weeks and 1st day,four weeks operation when compared with 1st before operation,there was statistically significant difference(P0.05).It significantly decreased 1st four weeks compared with 1st two weeks after operation,there was statistically significant difference(P0.05).Serum MG7-Ag、sIL-6R levels decreased after interventional treatment,it significantly decreased four weeks compared with 1st day before interventional treatment.There was statistically significant difference(P0.05),sIL-6R significantly decreased 1st four weeks compared with 1st two weeks after the treatment,however MG7-Ag、VEGF there was not statistically significant difference 1st four weeks compared with 1st two weeks after the treatment.The level of Serum MG7-Ag、sIL-6R changed more obviously after the interventional treatment compared with the intravenous chemotherapy,there was statistically significant difference.(F=4.356,P=0.0420.05、F=4.078,P=0.0490.05,F=4.389,P=0.0410.05).Conclusion To observe changes in serum MG7-Ag、sIL-6R、VEGF before and after transcatheter arterial chemo-embolization in patients with advanced gastric cancer.The lev
出处 《中国实验诊断学》 北大核心 2011年第5期853-856,共4页 Chinese Journal of Laboratory Diagnosis
关键词 中晚期胃癌 介入干预 MG7-AG SIL-6R VEGF advanced gastric cancer interventional treatment MG7-Ag VEGF SIL-2R
  • 相关文献

参考文献14

二级参考文献54

共引文献91

同被引文献25

  • 1巩曰红,刘少恒,朱丙炎,裴维芳.胃癌术后复发及残胃癌的供血动脉造影技术及介入治疗[J].介入放射学杂志,2005,14(1):77-78. 被引量:6
  • 2Jaffer AA. NCCN clinical practice guidelines in oncology: gastric cancer[M]. Bethesda: National Comprehensive Cancer Network, 2011. 被引量:1
  • 3Sakamoto J, Paoletti X. Meta- analyses of randomized trialsassessing the interest of postoperative adjuvant chemotherapy in gastric cancer[J]. J Clini Oncol(Meeting Abstracts), 2008, 26: 4543. 被引量:1
  • 4Yu W, Whang I, Chung HY, et al. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial [J ]. World J Surg, 2001, 25:985 -990. 被引量:1
  • 5Calvo K R, Liotta L A, Petricoin E F. Clinical proteomics: from biomarker discovery and cell signaling profiles to individu- alizedpermnal therapy[J]. Biosci Rep, 2005, 25(1 2): 107. 被引量:1
  • 6Zheng W E, Chen H, Yuan S F, et al. Overexpression of 13I -tubulin and survivin associated with drug resistance to doc- etaxel-based chemotherapy in advanced gastric cancer [J ]. J BUON, 2012, 17(2): 284. 被引量:1
  • 7Han J Y, Lim H S, Yoo Y K, et al. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharma- cokinetics and clinical outcome in patients with advanced non- small cell lung cancer[J]. Cancer, 2007, 110(1): 138. 被引量:1
  • 8Takakura A, Kurita A, A~sahara T, et al. Rapid deconjugation of SN-38 glucuronide and adsorption of released free SN-38 by intestinal microorganisms in rat[J]. Oncol Lett, 2012, 3(3) : 520,. 被引量:1
  • 9朱明德,张子敬,季洪胜,郝刚,葛成林,魏孔朋,袁玉厚,赵秀萍.进展期胃癌介入治疗疗效分析[J].介入放射学杂志,2008,17(2):136-139. 被引量:19
  • 10邢国臣,张寒梅,张怀亮,梁芳.胸苷酸合成酶的表达及其与胃癌的相关性[J].实用癌症杂志,2008,23(3):240-241. 被引量:6

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部